CervoMed (CRVO) Accounts Payables (2010 - 2026)
CervoMed (CRVO) reported Accounts Payables of $687,111 for Q2 2026, down 62.8% from $1.85 million a year earlier and down 69.8% from the prior quarter.
Powered by 
Analysis
CervoMed (CRVO) Accounts Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, CervoMed posted Accounts Payables of $1.45 million, down 3.8% from FY2024.
- Accounts Payables has a five-year compound annual growth rate of 21.6% (FY2020 to FY2025).
- By year, Accounts Payables came in at $1.51 million in FY2024 (+128.2%), $662,471 in FY2023 (+580.8%), $97,302 in FY2022 (-89.7%) and $947,495 in FY2021 (+73.6%).
- The Q2 2026 figure ranks as the lowest quarterly Accounts Payables since Q1 2024.
- Year over year, Accounts Payables gained in six of the last eight quarters, with growth averaging 67.4%.
- The high point for year-over-year Accounts Payables in five years was Q4 2023 (growth of 580.8%); the low point was Q4 2022 (a decline of 89.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2.27 million (Q1 2026), $1.45 million (Q4 2025) and $1.35 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 9.32 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 5.03 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 4.07 Bn |
| 10 | CervoMed | 14.36 Mn | -71.66 Mn | - | 687,111.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 687,111.00 |
| Mar 31, 2026 | 2.27 Mn |
| Dec 31, 2025 | 1.45 Mn |
| Sep 30, 2025 | 1.35 Mn |
| Jun 30, 2025 | 1.85 Mn |
| Mar 31, 2025 | 1.86 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Sep 30, 2024 | 1.08 Mn |
| Jun 30, 2024 | 725,854.00 |
| Mar 31, 2024 | 679,739.00 |
| Dec 31, 2023 | 662,471.00 |
| Sep 30, 2023 | 533,790.00 |
| Jun 30, 2023 | 932,427.00 |
| Mar 31, 2023 | 971,455.00 |
| Dec 31, 2022 | 97,302.00 |
| Sep 30, 2022 | 807,372.00 |
| Jun 30, 2022 | 846,032.00 |
| Mar 31, 2022 | 813,197.00 |
| Dec 31, 2021 | 947,495.00 |
| Sep 30, 2021 | 678,036.00 |
API Access
CervoMed Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=CRVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "CRVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=CRVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();